Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas

INTRODUCTION: The tight junction molecule Claudin 18.2 is selectively expressed in healthy and malignant gastric epithelial tissue and is a promising therapy target for high Claudin 18.2 expressing adenocarcinomas of the esophagogastric junction and stomach (AEG/S). METHODS: This study analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, A., Daum, S., von Winterfeld, M., Berg, E., Hummel, M., Rau, B., Stein, U., Treese, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Brief Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577914/
https://www.ncbi.nlm.nih.gov/pubmed/32488802
http://dx.doi.org/10.1007/s12094-020-02380-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577914/
https://www.ncbi.nlm.nih.gov/pubmed/32488802
http://dx.doi.org/10.1007/s12094-020-02380-0

Ejemplares similares